SCHEMBL19081784

SCHEMBL19081784

c1ccc(-c2c3ccccc3c(-c3cc4c5cc6ccccc6cc5oc4c4sc5ccccc5c34)c3ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 5/20 0.38
ESR1 P03372 4/20 0.37
PTPN1 P18031 2/20 0.33
TNKS O95271 1/20 0.31
TNKS2 Q9H2K2 1/20 0.31
ALOX5 P09917 1/20 0.31
MAPK1 P28482 1/20 0.31
KMT2A Q03164 1/20 0.31
ELANE P08246 1/20 0.31
PTPRC P08575 1/20 0.30
PTPRF P10586 1/20 0.30
PTPRA P18433 1/20 0.30
PTPRB P23467 1/20 0.30
PTPN6 P29350 1/20 0.30
DUSP3 P51452 1/20 0.30
PTPN12 Q05209 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17944373 0.82 ESR2 (0.39) ESR2ESR1PTPN1TNKSTNKS2
SCHEMBL19082008 0.82 TNKS (0.34) ESR2ESR1PTPN1TNKSTNKS2
SCHEMBL19081777 0.81 ESR2 (0.36) ESR2ESR1PTPN1ALOX5ELANE
SCHEMBL19081772 0.81 ESR2 (0.36) ESR2ESR1PTPN1ELANE
SCHEMBL19081884 0.81 ESR1 (0.33) ESR2ESR1PTPN1
SCHEMBL19082010 0.81 ABCG2 (0.37) ESR2ESR1PTPN1MAPK1KMT2A
SCHEMBL19081902 0.81 ABCG2 (0.38) ESR2ESR1PTPN1MAPK1KMT2A
SCHEMBL17944424 0.81 ESR2 (0.36) ESR2ESR1PTPN1ALOX5
SCHEMBL24877104 0.81 ESR2 (0.36) ESR2ESR1PTPN1
SCHEMBL19081883 0.81 CYP1A1 (0.37) MAPK1KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR2 542/4885ESR1 225/4885PTPN1 4695/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR2 542/4885ESR1 225/4885PTPN1 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.